{
  "ptid_time": "027_S_4943_2012-09-18",
  "img_path": "/data/qiuhui/data/adni/images/027_S_4943/2012-09-18/t1.nii.gz",
  "img_finding": "Image findings: whole brain volume measures 1,142,560 mm³, 5.9% above the reference mean. With a Z-score of 0.76 (77.6th percentile), this represents normal volume . ",
  "text_data": "Age is 76.1 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Gastrointestinal; Renal-Genitourinary; Smoking; Major Surgical Procedures. MMSE: 26.0. MoCA: 22.0. Logical Memory: 7.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.41 SUVR (significant elevated); Amyloid beta: 443.80 pg/mL (moderate reduced); Total tau: 267.10 pg/mL (normal ); Phosphorylated tau: 26.51 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain volume is within normal range, and cognitive scores (MMSE 26, MoCA 22) suggest mild cognitive impairment rather than dementia. Elevated AV45 (amyloid PET) and moderately reduced Aβ (CSF) indicate amyloid pathology, but normal tau levels (T-tau, P-tau) suggest no significant neurodegeneration.  \n**Diagnosis:** **MCI** (likely due to Alzheimer’s pathology given amyloid elevation).  \n**Confidence:** **Medium** (amyloid burden supports MCI due to AD, but tau normality and near-normal cognition leave some uncertainty).",
  "timestamp": "2025-07-26T04:04:26.509176"
}